313 results on '"Salvestrini, V."'
Search Results
2. Tumor-associated macrophages (TAMs) modulate response to HER2-targeted agents in a humanized mouse model of breast cancer
3. Stereotactic Re-irradiation in Recurrent Prostate Cancer after Previous Postoperative or Definitive Radiotherapy: Long-term Results after a Median Follow-up of 4 Years
4. Pattern of Recurrence After Stereotactic Radiotherapy in Prostate Cancer Patients With Nodal Pelvic Relapse. A Multi-Institutional Retrospective Analysis
5. The impact of modern radiotherapy on long-term cardiac sequelae in breast cancer survivor: a focus on deep inspiration breath-hold (DIBH) technique
6. Toxicity after moderately hypofractionated versus conventionally fractionated prostate radiotherapy: A systematic review and meta-analysis of the current literature
7. Prospective assessment of AR splice variant and PSMA detection on circulating tumor cells of mCRPC patients: preliminary analysis of patients enrolled in PRIMERA trial (NCT04188275)
8. Impact of COVID-19 on patient–doctor interaction in a complex radiation therapy facility
9. Correction to: Impact of COVID-19 on patient–doctor interaction in a complex radiation therapy facility
10. Diastolic function is more sensitive than GLS in identifing cardiotoxicity. The SAFE trial results
11. The right ventricle is not spared by the cardiotoxic effects of chemotherapy for breast cancer. Results of SAFE trial
12. Cardioprotection beyond the guidelines: the SAFE trial results
13. Cardiological Safety of 5-Fraction Whole Breast Irradiation
14. Three Months PSA Response after PSMA-Guided Approach for Biochemical Relapse after Prostatectomy (PSICHE Trial)
15. Ultra-Central Tumors Treated with Stereotactic Body Radiotherapy: Clinical Outcome and Prognostic Factors
16. Long Term Clinical Outcomes of a Cohort of Lung-Only Oligometastatic HNSCC Patients Treated with SBRT
17. PO-1184 Hypofractionated re-irradiation for locoregionally recurrent head and neck cancer
18. PD-0576 Stereotactic reirradiation for locally recurrent prostate cancer after definitive radiotherapy
19. PO-1269 Cardiological monitoring and safety of 5-fraction whole breast irradiation: SAFE-FORWARD study
20. PO-1109 Safety and efficacy of silibinin in patients with brain metastases after SRS: SUSTAIN trial
21. PO-1193 Pattern of practice in elderly patients with HPV positive oropharyngeal cancer: a multicenter study
22. PD-0397 Clinical outcome of lung-only oligometastatic HNSCC patients treated with SBRT: Update results
23. PO-1329 Survival and prognostic factors of ultra-central tumors treated with stereotactic body radiotherapy
24. PO-1391 Dose intensification in Locally Advanced Pancreatic Cancer using Robotic SBRT
25. PO-1354 Pattern of failure after stereotactic body radiotherapy to liver metastases: impact of local control
26. PO-1459 Stereotactic salvage radiotherapy for prostate red relapse, early analysis from a prospective trial
27. P106 De-escalation of radiation therapy after primary systemic therapy in non-metastatic breast cancer: patterns of recurrence from a real-world single-centre cohort of patients
28. Radiotherapy in patients receiving anthracyclines: phase 3 SAFE trial (NCT2236806) interim analysis
29. Immunological profile and cytokine dynamics in head and neck cancer patients treated with radio-immunotherapy
30. Intra- and Inter-Fraction Errors and Deformation during Pancreas SBRT: Analysis and Predictability of Dose Variations for Upper Gastrointestinal Organs
31. Acupuncture for (Chemo)Radiotherapy – Related Dysphagia in Patients with Head and Neck Squamous Cell Carcinoma (HNSCC): A Randomized Phase 2 Study
32. A Prospective Observational Trial on Ablative SBRT for Mediastinal and Hilar Lymph nodes: Preliminary Results
33. Safe Deviation from the “5+5” Expansion Rule for the Delineation of Primary Tumor Clinical Target Volume (CTV-P) in Oropharyngeal Cancer: A Prospective Cohort Study
34. Early Results from a Prospective Trial Testing Stereotactic Salvage Radiotherapy for Macroscopic Prostate Bed Recurrence after Prostatectomy-STARR(NCT05455736)
35. Neoadjuvant (Chemo-) Radiotherapy for Locally Advanced Soft Tissue Sarcoma
36. Preoperative Radiosurgery on Early Breast Cancer Patients: Analysis of Tumor Genetic Background and Tumor Immune Microenvironment
37. Assessment of Local Control and Pain Relief of Rib Metastases Treated with SBRT
38. 379P Safety and efficacy of trastuzumab deruxtecan and concomitant radiation therapy in patients with metastatic breast cancer: A multicentre international retrospective cohort study
39. A critical review on oligometastatic disease: a radiation oncologist’s perspective
40. PO-1363 Detection rate of 68Ga-PSMA PET/CT from a prospective study: PSICHE trial (NCT05022914)
41. OC-0605 Early outcomes of a randomized trial of SBRT and Abiraterore in mCPRC: ARTO trial NCT03449719
42. PO-1299 Charlson Comorbidity Index for patients selection in definitive chemoradiation for anal carcinoma
43. PD-0411 Predictive factors of late GU toxicity after Cyberknife re-irradiation for locally recurrent PCa
44. PO-1137 Safety And Efficacy Of Silibinin In Patients With Brain Metastases after Radiosurgery: Sustain Trial
45. The impact of modern radiotherapy on long-term cardiac sequelae in breast cancer survivor: a focus on deep inspiration breath-hold (DIBH) technique
46. Nivolumab in elderly patients with recurrent/metastatic head and neck squamous cell carcinoma: efficacy and safety data from a monocentric experience
47. Correction to: Impact of COVID-19 on patient–doctor interaction in a complex radiation therapy facility
48. Concomitant immuno-radiotherapy in metastatic renal cell carcinoma: multicenter analysis
49. PO-1316 Stereotactic radiotherapy in recurrent prostate cancer after postoperative or definitive irradiation
50. PO-1366 Pattern of recurrence after SBRT in prostate cancer patients with nodal pelvic relapse
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.